Status:
WITHDRAWN
Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
Lead Sponsor:
Hôpital le Vinatier
Conditions:
Gender Dysphoria
Eligibility:
MALE
18-50 years
Phase:
NA
Brief Summary
The aim of the research is to study longitudinally the effects of reassignment hormonotherapy on the connectome of MtF (biological men who are transitioning to the female gender) dysphoric subjects af...
Detailed Description
The pathophysiology of gender dysphoria is still poorly understood, but a number of clues point to an origin derived from biological and environmental factors, particularly studies of twins, birth ord...
Eligibility Criteria
Inclusion
- gender dysphoric subjects MtF
- right handed
- androphilic orientation
- without hormone therapy
- Control group of male subjects:
- right handed
- without any psychiatric or medical history
- androphilic orientation
Exclusion
- MRI contraindication
- vulnerable adults
- mental retardation
- psychiatric or neurological disease including autism spectrum disorders, psychotropic medication
- hormonal or genetic condition
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2022
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04309760
Start Date
February 1 2021
End Date
March 15 2022
Last Update
April 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.